» Articles » PMID: 21791618

Hormonal Factors and the Risk of Papillary Thyroid Cancer in the California Teachers Study Cohort

Overview
Date 2011 Jul 28
PMID 21791618
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the increasing incidence of thyroid cancer, there is limited information on its etiology. The strikingly higher rates in young women, compared with men, suggest that sex steroid hormones may be involved in the development of this disease.

Methods: We investigated the effects of menstrual, reproductive, and other hormonal factors on papillary thyroid cancer risk in the prospective California Teachers Study cohort. Among 117,646 women, 233 were diagnosed with invasive histologically confirmed papillary thyroid cancer after cohort enrollment and before January 1, 2008. Relative risks (RR) and 95% CIs were estimated by using Cox proportional hazards regression models.

Results: Among younger women (age <45 years at baseline; approximately one-third of the cohort), but not older women, later age at menarche (age ≥14 years) was associated with increased risk (RR = 1.88, 95% CI: 1.13-3.13; p(interaction) by age = 0.06). Risk was also increased among young women who had longer (>30 days) adolescent menstrual cycles (RR = 1.78, 95% CI: 1.01-3.14) and whose last pregnancy had ended within five years of cohort enrollment (RR = 2.21, 95% CI: 1.13-4.34). Among older women (age ≥45 years at baseline), ever use of estrogen-only therapy was associated with a statistically nonsignificant increase in risk (RR = 1.69, 95% CI: 0.95-2.98).

Conclusions: The findings from this prospective analysis suggest that several factors related to delayed pubertal development and the transient effects of pregnancy may be particularly important in influencing risk in young women.

Impact: These results suggest the importance of future research into the role of progesterone and the estrogen-to-progesterone ratio.

Citing Articles

Exploring the Correlation Between Papillary Thyroid Carcinoma (PTC) and the Usage of Oral Contraceptive Pills Among Affected Females.

Alsinni H, Alwasiyah B, Alwagdani A, Namenkani M, Althomali R, Alsulami A Cureus. 2024; 16(8):e65998.

PMID: 39221305 PMC: 11366211. DOI: 10.7759/cureus.65998.


Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.

Kitahara C, Surcel H, Falk R, Pfeiffer R, MaNnisto T, Gissler M Int J Cancer. 2024; 155(6):1014-1022.

PMID: 38693841 PMC: 11250719. DOI: 10.1002/ijc.34974.


Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.

OGrady T, Rinaldi S, Michels K, Adami H, Buring J, Chen Y Int J Epidemiol. 2023; 53(1).

PMID: 38110618 PMC: 10859160. DOI: 10.1093/ije/dyad172.


Clinical, cytological and ultrasonographic features of incidental thyroid cancer in a hospital-based study in vietnam.

Quang Nguyen B, Tran H, Nguyen H, Nguyen T, Nguyen T, Nguyen T Endocrinol Diabetes Metab. 2023; 6(3):e415.

PMID: 36896571 PMC: 10164435. DOI: 10.1002/edm2.415.


BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors.

Kim M, Kim S, Ha S, Xu Z, Han Y, Jee H Endocrinol Metab (Seoul). 2023; 37(6):879-890.

PMID: 36604958 PMC: 9816508. DOI: 10.3803/EnM.2022.1563.


References
1.
Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P . Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol. 2005; 161(11):1056-65. PMC: 2668936. DOI: 10.1093/aje/kwi136. View

2.
Memon A, Darif M, Al-Saleh K, Suresh A . Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer. 2002; 97(1):82-9. DOI: 10.1002/ijc.1573. View

3.
Kawabata W, Suzuki T, Moriya T, Fujimori K, Naganuma H, Inoue S . Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Mod Pathol. 2003; 16(5):437-44. DOI: 10.1097/01.MP.0000066800.44492.1B. View

4.
Preston-Martin S, Franceschi S, Ron E, Negri E . Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?. Cancer Causes Control. 2003; 14(8):787-9. DOI: 10.1023/a:1026312203045. View

5.
Mack W, Preston-Martin S, Bernstein L, Qian D, Xiang M . Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev. 1999; 8(11):991-7. View